[The clinical significance of endothelin].
Fyhrquist
F
F
Department of Internal Medicine, Helsinki University Central Hospital and Minerva Medical Research Institute, Helsinki, Finland.
Saijonmaa
O
O
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000503:physiopathology; D019332:Endothelin-1 / Q000009:adverse effects / Q000096:biosynthesis; D019333:Endothelin-2 / Q000009:adverse effects / Q000096:biosynthesis; D019334:Endothelin-3 / Q000009:adverse effects / Q000096:biosynthesis; D016232:Endothelins / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D011322:Primary Prevention / Q000379:methods; D011379:Prognosis; D014661:Vasoconstriction
D019332:Endothelin-1; D019333:Endothelin-2; D019334:Endothelin-3; D016232:Endothelins